Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is -4.31% vs 6.65% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -8.09% vs 2.26% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -82.27% vs 0.58% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is -21.77% vs -17.88% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
Compare Quarterly Results Of Beijing Beilu Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is -4.31% vs 6.65% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 14.17% vs 19.31% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -8.09% vs 2.26% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 228.95% vs 141.30% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -82.27% vs 0.58% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -79.60% vs 176.69% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -21.77% vs -17.88% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -38.99% vs 11.19% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






